The Jan. 12, 2017, joint meeting of the NCATS Advisory Council and the Cures Acceleration Network Review Board featured the following meeting materials.
Presentations
- NCATS Director's Report (2.15 - MB) Christopher P. Austin, M.D., director, NCATS
- CAN Review Board Update (240 - KB) Freda C. Lewis-Hall, M.D., chief medical officer, Pfizer
- Office of Rare Disease Update (1.53 - MB) Petra Kaufmann, M.D., M.Sc., director, Office of Rare Diseases Research and the Division of Clinical Innovation, NCATS